Dr. Roh is an Assistant Professor of Neurology at Columbia University Irving Medical Center. He is an Attending Neurointensivist Physician at NewYork-Presbyterian Hospital and joined as faculty in 2016. Prior to joining as faculty, Dr. Roh received his undergraduate degree from The University of Illinois at Urbana Champaign and his medical degree from Rush Medical College. He completed Neurology Residency at The University of Miami/Jackson Memorial Hospital followed by Neurocritical Care fellowship training at NewYork-Presbyterian: Columbia and Cornell Medical Centers.

Dr. Roh is board certified in Neurology and Neurocritical Care and he specializes in the treatment of neurological emergencies and critical illness in the Neurosciences Intensive Care Unit.

He is a clinical investigator whose research characterizes coagulopathy in critically ill patients, specifically in those who encounter brain bleeding. Dr. Roh leads a translational research team whose focus is to develop novel laboratory diagnostic strategies and hemorrhage control therapy approaches to improve clinical outcomes in patients who encounter life threatening bleeding. His work is currently supported by the NIH (NINDS, NHLBI), the Department of Defense, and the National Blood Foundation. He currently serves as a senior advisory board member of the American Heart Association Hemorrhagic Stroke Science Committee.